Navigation Links
Engineered microbes grow in the dark
Date:5/19/2013

Scientists at the University of California, Davis have engineered a strain of photosynthetic cyanobacteria to grow without the need for light. They report their findings today at the 113th General Meeting of the American Society for Microbiology.

"In this work, we used synthetic biology approaches to probe and rewire photoautotrophic (exclusively relying on carbon dioxide and light energy for growth) cyanobacterial metabolism for the ability to grow without light energy," says Jordan McEwen, the lead researcher on the study. He is part of Shota Atsumi's lab at the university, a research group focused on developing synthetic organisms capable of converting carbon dioxide directly to biofuels.

The cyanobacterium strain Synechococcus elongatus strain PCC 7942 has been well characterized as a model photoautotroph. Previous work by Atsumi's lab has engineered this organism to recycle carbon dioxide into a variety of biofuels and valuable chemicals in the presence of light. Any cost-effective, cyanobacterial biofuel production scheme would use natural lighting conditions, limiting how much biofuel could be produced in a 24-hour period.

"To overcome this constraint, we installed foreign genes into S. elongatus to allow this cyanobacterium to grow and generate biofuels in diurnal (light or dark) conditions," says McEwen. "With recent, increased focus on cyanobacteria-based industrial applications, this advancement is desirable for more efficient, economical and controllable bioproduction systems."


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. Europe needs genetically engineered crops, scientists say
2. Recruiting engineered cells to work for warfighters
3. Market Analysis: Biomaterials and Engineered Protein
4. Painting with catalysts: Nano-engineered materials for detoxifying water by use of sunlight
5. Engineered bacteria make fuel from sunlight
6. Production of 5-aminovaleric and glutaric acid by metabolically engineered microorganism
7. Engineered immune cells produce complete response in child with an aggressive pediatric leukemia
8. Leukemia patients remain in remission more than 2 years after engineered T cell therapy
9. Bioengineered marine algae expands environments where biofuels can be produced
10. Soft Robotics: A groundbreaking new journal on engineered soft devices that Interact with Living Systems
11. Engineered bacteria can make the ultimate sacrifice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/28/2017)... , February 28, 2017 News solutions for ... ... from 14 to 16 March, Materna will present ... show how seamless travel is a real benefit for passengers. ... biometrics to their passenger touch point solutions to take passengers through ...
(Date:2/26/2017)... Feb. 25, 2017  Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring, announces ... Reentry. "Too often, too many offenders ... county jails are trying to tackle this ongoing ... friends and family members. While significant steps are underway, ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
(Date:3/22/2017)... 22, 2017   Boston Biomedical , an industry ... to target cancer stemness pathways, today announced its Board ... as Chief Executive Officer, effective April 24, 2017. ... Li , M.D., FACP, who has led Boston Biomedical ... his leadership, Boston Biomedical has grown from a "garage ...
Breaking Biology Technology: